title: Suppression of the tetrodotoxin-resistant sodium channel (PN3/SNS): a possible new treatment for bladder pain.
authors.affiliation: Department of Pharmacology and Urology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
authors.forename: N
authors.initials: N
authors.lastname: Yoshimura
authors.forename: S
authors.initials: S
authors.lastname: Seki
authors.forename: V
authors.initials: V
authors.lastname: Erickson
authors.forename: K
authors.initials: K
authors.lastname: Erickson
authors.forename: L
authors.initials: L
authors.lastname: Kassotakis
authors.forename: S
authors.initials: S
authors.lastname: Novakovic
authors.forename: M O
authors.initials: MO
authors.lastname: Fraser
authors.forename: M B
authors.initials: MB
authors.lastname: Chancellor
authors.forename: W C
authors.initials: WC
authors.lastname: de Groat
mesh_terms: D019342:Acetic Acid; D000818:Animals; D004351:Drug Resistance; D005260:Female; D007202:Indicators and Reagents; D062559:NAV1.8 Voltage-Gated Sodium Channel; D020319:Oligodeoxyribonucleotides, Antisense / Q000627:therapeutic use*; D010146:Pain / Q000139:chemically induced / Q000378:metabolism; D059408:Pain Management; D016760:Proto-Oncogene Proteins c-fos / Q000378:metabolism; D051381:Rats; D015222:Sodium Channels / Q000187:drug effects* / Q000378:metabolism; D013779:Tetrodotoxin / Q000494:pharmacology; D001743:Urinary Bladder / Q000187:drug effects* / Q000294:innervation / Q000378:metabolism; D001745:Urinary Bladder Diseases / Q000139:chemically induced / Q000378:metabolism / Q000628:therapy*
chemical_list: D007202:Indicators and Reagents; D062559:NAV1.8 Voltage-Gated Sodium Channel; D020319:Oligodeoxyribonucleotides, Antisense; D016760:Proto-Oncogene Proteins c-fos; C568319:Scn10a protein, rat; D015222:Sodium Channels; D013779:Tetrodotoxin; D019342:Acetic Acid